Toshiba Corp. plans to gradually unload its 40.2 percent stake in Kioxia Holdings when the latter lists its shares in an IPO later this year.
So far, Toshiba has not finalized its decision over its stake in Kioxia, the world's second-largest flash memory chip firm.
Among the various possibilities is the distribution to shareholders of about half or more of after-tax proceeds from the sale back.
Kioxia was Toshiba's memory chip business until selling it to a consortium led by U.S. private equity firm Bain Capital for $18 billion in 2018.
Toshiba later repurchased 40.2 percent of common stock in Kioxia.
The initial public offering of Kioxia is estimated market valuation to reach $32 billion in an IPO as early as October and could be Japan's biggest listing this year.
Toshiba is being urged by overseas fund investors to sell its stake Kioxia due to the highly volatile nature of the flash memory chips business that could sway the company's earnings.


Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Google Secures Pentagon AI Deal for Classified Projects
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales 



